228 related articles for article (PubMed ID: 37749552)
1. LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration.
Hong JM; Lee JW; Seen DS; Jeong JY; Huh WK
Cell Commun Signal; 2023 Sep; 21(1):257. PubMed ID: 37749552
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration.
Park C; Lee JW; Kim K; Seen DS; Jeong JY; Huh WK
Sci Rep; 2023 Feb; 13(1):1894. PubMed ID: 36732336
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (C
Gao X; Cheng YH; Enten GA; DeSantis AJ; Gaponenko V; Majetschak M
J Biol Chem; 2020 Oct; 295(44):14893-14905. PubMed ID: 32839271
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
[TBL] [Abstract][Full Text] [Related]
5. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.
Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T
Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676
[TBL] [Abstract][Full Text] [Related]
6. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α
Gao X; Enten GA; DeSantis AJ; Volkman BF; Gaponenko V; Majetschak M
Biochem Biophys Res Commun; 2020 Jul; 528(2):368-375. PubMed ID: 32085899
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.
Nijmeijer S; Leurs R; Smit MJ; Vischer HF
J Biol Chem; 2010 Sep; 285(38):29632-41. PubMed ID: 20622011
[TBL] [Abstract][Full Text] [Related]
8. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
9. G protein activation via chemokine (C-X-C motif) receptor 4 and α
Gao X; Majetschak M
FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
[TBL] [Abstract][Full Text] [Related]
10. Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.
Watts AO; van Lipzig MM; Jaeger WC; Seeber RM; van Zwam M; Vinet J; van der Lee MM; Siderius M; Zaman GJ; Boddeke HW; Smit MJ; Pfleger KD; Leurs R; Vischer HF
Br J Pharmacol; 2013 Apr; 168(7):1662-74. PubMed ID: 23170857
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
12. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
Décaillot FM; Kazmi MA; Lin Y; Ray-Saha S; Sakmar TP; Sachdev P
J Biol Chem; 2011 Sep; 286(37):32188-97. PubMed ID: 21730065
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
14. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
Drury LJ; Ziarek JJ; Gravel S; Veldkamp CT; Takekoshi T; Hwang ST; Heveker N; Volkman BF; Dwinell MB
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17655-60. PubMed ID: 21990345
[TBL] [Abstract][Full Text] [Related]
15. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
16. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
17. α
Gao X; Enten GA; McGee MY; Weche M; Majetschak M
Pharmacol Res; 2023 Apr; 190():106730. PubMed ID: 36925091
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 Antagonists: A Screening Strategy for Identification of Functionally Selective Ligands.
Castaldo C; Benicchi T; Otrocka M; Mori E; Pilli E; Ferruzzi P; Valensin S; Diamanti D; Fecke W; Varrone M; Porcari V
J Biomol Screen; 2014 Jul; 19(6):859-69. PubMed ID: 24632660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
